Get the Stockscreener App
1.04
0.70%
-0.0073
After Hours:
1.04
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Abvc Biopharma Inc Stock (ABVC) Forecast
The Abvc Biopharma Inc (ABVC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.8526, representing a +462.75% increase from the current price of $1.04. The highest analyst price target is $10.18, and the lowest is $1.5221.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ABVC Price Target
Average 5.2677
(+406.51% Upside)
Is Abvc Biopharma Inc (ABVC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.68 | Neutral |
| STOCH(9,6) | 48.11 | Neutral |
| STOCHRSI(14) | 94.54 | Sell |
| MACD(12,26) | -0.00796 | Buy |
| ADX(14) | 14.18 | Neutral |
| William %R | -15.75 | Sell |
| CCI(14) | 70.47 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9757
Buy
|
0.9922
Buy
|
| MA20 |
0.9933
Buy
|
0.9966
Buy
|
| MA50 |
0.976
Buy
|
1.0237
Buy
|
| MA100 |
1.137
Sell
|
1.1152
Sell
|
| MA200 |
1.2842
Sell
|
1.4303
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, ABVC could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 6 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on ABVC, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 54.68 indicates that ABVC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 48.11 indicates that ABVC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 94.54 indicates that ABVC is oversold. This suggests that ABVC price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.18 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 70.47 indicates that ABVC is still overbought but not to an extreme extent.
Long-term ABVC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Abvc Biopharma Inc financial reports and earnings history, Abvc Biopharma Inc (ABVC) stock could reach $0.3008 by 2030, $3.1625 by 2040 and $4.80 by 2050. See the projected annual prices until 2050 of the Abvc Biopharma Inc stock below:
- Abvc Biopharma Inc (ABVC) is expected to reach an average price of $0.8756 in 2035, with a high prediction of $0.8937 and a low estimate of $0.7916. This indicates an $-15.81% rise from the last recorded price of $1.04.
- Abvc Biopharma Inc (ABVC) stock is projected to chart a bullish course in 2040, with an average price target of $3.2225, representing an $209.86% surge from its current level. The forecast ranges from a conservative $3.1098 to a sky-high $3.1625.
- Our analysts predict Abvc Biopharma Inc (ABVC) to jump 334.19% by 2045, soaring from $4.5298 to an average price of $4.5156, potentially reaching $4.5019. While $4.5298 is the low estimate, the potential upside is significant.
- Abvc Biopharma Inc (ABVC) stock is expected to climb by 2050, reaching an average of $5.0847, a $388.92% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.80 and $4.7902, respectively, highlighting the market's uncertainty.
Abvc Biopharma Inc Stock (ABVC) Year by Year Forecast
Abvc Biopharma Inc Stock (ABVC) Price Forecast for 2026
The predicted value for Abvc Biopharma Inc (ABVC) in 2026 is set at an average of $5.445. Estimates vary from a peak of $10.18 to a trough of $0.7069, indicating an +423.55% surge from the present price of $1.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.5452 | $1.5221 | $10.18 | +48.57% |
| December, 2026 | $2.2873 | $1.4212 | $2.7712 | +119.93% |
Abvc Biopharma Inc Stock (ABVC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Abvc Biopharma Inc (ABVC) is $1.4094, with a high forecast of $2.4664 and a low forecast of $0.3524. This indicates an +35.52% increase from the last price of $1.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.2494 | $1.2494 | $2.4664 | +20.13% |
| February, 2027 | $1.1815 | $0.9355 | $1.2385 | +13.61% |
| March, 2027 | $0.8367 | $0.7567 | $1.6367 | -19.55% |
| April, 2027 | $1.2788 | $0.7097 | $1.4658 | +22.96% |
| May, 2027 | $1.049 | $0.8109 | $1.7018 | +0.86% |
| June, 2027 | $0.5761 | $0.5431 | $1.487 | -44.61% |
| July, 2027 | $0.4019 | $0.4948 | $0.6991 | -61.36% |
| August, 2027 | $0.5923 | $0.4289 | $0.4966 | -43.04% |
| September, 2027 | $0.4945 | $0.7236 | $0.6606 | -52.45% |
| October, 2027 | $0.2524 | $0.3524 | $0.4615 | -75.73% |
| November, 2027 | $0.6372 | $0.5253 | $0.4072 | -38.73% |
| December, 2027 | $0.592 | $0.5981 | $0.5918 | -43.08% |
Abvc Biopharma Inc Stock (ABVC) Price Forecast for 2028
In 2028, Abvc Biopharma Inc (ABVC) is projected to reach an average price of $2.8378, with a high projection of $5.6722 and a low estimate of $0.00341. This indicates an +172.87% rise from the last price of $1.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5451 | $0.60 | $0.563 | -47.59% |
| February, 2028 | $0.6728 | $0.6339 | $0.6078 | -35.31% |
| March, 2028 | $0.5258 | $0.4666 | $0.5752 | -49.44% |
| April, 2028 | $0.5486 | $0.5727 | $0.5396 | -47.25% |
| May, 2028 | $0.6584 | $0.5998 | $0.5615 | -36.69% |
| June, 2028 | $0.6285 | $0.6363 | $0.5944 | -39.57% |
| July, 2028 | $0.5015 | $0.4542 | $0.5271 | -51.78% |
| August, 2028 | $0.599 | $0.5551 | $0.542 | -42.40% |
| September, 2028 | $0.7398 | $0.641 | $0.6699 | -28.87% |
| October, 2028 | $1.5483 | $0.7839 | $5.6722 | +48.87% |
| November, 2028 | $0.1304 | $0.00962 | $1.5613 | -87.46% |
| December, 2028 | $0.2875 | $0.00341 | $0.1895 | -72.36% |
Abvc Biopharma Inc Stock (ABVC) Price Forecast for 2029
The 2029 price forecast for Abvc Biopharma Inc Stock (ABVC) is $1.0992 on average, with a high prediction of $2.1977 and a low estimate of $0.000718. This represents an +5.69% increase from the previous price of $1.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.2277 | $0.2812 | $2.1977 | -78.11% |
| February, 2029 | $0.4098 | $0.0963 | $0.6398 | -60.60% |
| March, 2029 | $0.0619 | $0.0319 | $1.0828 | -94.05% |
| April, 2029 | $0.3171 | $0.021 | $1.334 | -69.51% |
| May, 2029 | $0.3992 | $0.0901 | $0.4362 | -61.62% |
| June, 2029 | $0.1213 | $0.0583 | $0.3982 | -88.34% |
| July, 2029 | $0.2365 | $0.0216 | $0.3765 | -77.26% |
| August, 2029 | $0.3586 | $0.0175 | $0.6686 | -65.52% |
| September, 2029 | $0.0207 | $0.000718 | $0.3915 | -98.01% |
| October, 2029 | $0.3211 | $0.1443 | $0.2339 | -69.12% |
| November, 2029 | $0.196 | $0.241 | $0.2524 | -81.15% |
| December, 2029 | $0.3474 | $0.2969 | $0.29 | -66.59% |
Abvc Biopharma Inc Stock (ABVC) Price Forecast for 2030
Abvc Biopharma Inc Stock (ABVC) is expected to reach an average price of $1.1541 in 2030, with a high forecast of $2.2708 and a low forecast of $0.0375. This signifies an +10.98% surge from the last price of $1.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.3006 | $0.3397 | $0.3008 | -71.09% |
| February, 2030 | $0.3626 | $0.3355 | $0.2978 | -65.13% |
| March, 2030 | $0.2795 | $0.3305 | $0.3356 | -73.13% |
| April, 2030 | $0.4253 | $0.3284 | $0.4053 | -59.10% |
| May, 2030 | $0.362 | $0.4532 | $0.4293 | -65.19% |
| June, 2030 | $0.3911 | $0.3471 | $0.3531 | -62.40% |
| July, 2030 | $0.2163 | $0.4144 | $0.4589 | -79.20% |
| August, 2030 | $0.2138 | $0.24 | $0.1938 | -79.44% |
| September, 2030 | $0.0336 | $0.0386 | $0.5053 | -96.77% |
| October, 2030 | $0.3335 | $0.0375 | $0.4835 | -67.93% |
| November, 2030 | $0.6756 | $0.2395 | $0.9456 | -35.04% |
| December, 2030 | $2.2608 | $0.6879 | $2.2708 | +117.38% |
3.09%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):